Kewaunee Scientific Corporation (KEQU)
| Market Cap | 106.08M +8.5% |
| Revenue (ttm) | 287.75M +30.8% |
| Net Income | 11.08M -37.0% |
| EPS | 3.72 -37.0% |
| Shares Out | 2.87M |
| PE Ratio | 9.95 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,944 |
| Open | 35.43 |
| Previous Close | 36.48 |
| Day's Range | 35.43 - 37.63 |
| 52-Week Range | 32.60 - 60.89 |
| Beta | 0.69 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 24, 2026 |
About KEQU
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company’s laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical,... [Read more]
Financial Performance
In fiscal year 2025, Kewaunee Scientific's revenue was $240.47 million, an increase of 18.02% compared to the previous year's $203.76 million. Earnings were $11.41 million, a decrease of -39.18%.
Financial StatementsNews
Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group
STATESVILLE, N.C., April 14, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, furth...
Kewaunee Scientific reports Q3 adjusted EPS 28c vs. 1.09 last year
Reports Q3 revenue $69.4M vs. $67.47M last year. “Following the successful turnaround of the business, we embarked on a strategy that accelerated inorganic growth, which led to the successful completi...
Kewaunee Scientific reports Q3 EPS 32c vs. 45c last year
Reports Q3 revenue $69.4M vs. $67.47M last year. “Following the successful turnaround of the business, we embarked on a strategy that accelerated inorganic growth, which led to the successful completi...
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026
STATESVILLE, N.C., March 11, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2026.
Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich
STATESVILLE, N.C., March 3, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2026 analytica tradeshow and conference, taking place i...
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026
STATESVILLE, N.C., Feb. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2026 financial results o...
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026
STATESVILLE, N.C. , Dec. 10, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2025.
Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.
STATESVILLE, N.C. , Dec. 4, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technic...
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026
STATESVILLE, N.C. , Nov. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial results...
Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors
STATESVILLE, N.C. , Sept. 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and techn...
Kewaunee Scientific reports Q1 EPS $1.04 vs. 74c last year
Reports Q1 revenue $71.1M vs. $48.3M last year. “Our Domestic and International segments delivered solid financial performance in Q1 despite challenging market conditions as a result of uncertain gove...
Kewaunee Scientific reports Q1 EPS $1.04 vs. 74c last year
Reports Q1 revenue $71.1M vs. $48.3M last year. “Our Domestic and International segments delivered solid financial performance in Q1 despite challenging market conditions as a result of uncertain gove...
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026
STATESVILLE, N.C. , Sept. 10, 2025 /PRNewswire/ -- PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2025.
Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai
STATESVILLE, N.C. , Sept. 2, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking pla...
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026
STATESVILLE, N.C. , Aug. 27, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2026 financial results ...
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
STATESVILLE, N.C. , June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025.
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
STATESVILLE, N.C. , June 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal y...
Kewaunee Scientific announces amendment to share repurchase program
Kewaunee Scientific (KEQU) announced an amendment to its existing share repurchase program. The Board of Directors of Kewaunee Scientific amended its existing share repurchase program initially approv...
Kewaunee Scientific Announces Amendment to Share Repurchase Program
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced an amendment to its existing share repurchase program.
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2025.
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025
STATESVILLE, N.C. , Feb. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2025 financial results ...
Kewaunee Scientific reports Q3 EPS $1.01 vs. 93c last year
Reports Q3 revenue $47.75M vs. $50.44M last year. “Our financial performance for the second quarter of fiscal year 2025 was strong,” said CEO Thomas Hull III. “Domestic segment operating performance
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
STATESVILLE, N.C. , Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2024.
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
STATESVILLE, N.C. , Nov. 27, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2025 financial results...
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
STATESVILLE, N.C. , Nov. 1, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) Kewaunee Scientific Corporation ("Kewaunee"), a leader in laboratory furniture and technical product des...